Investing.com - GlaxoSmithKline ADR reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
GlaxoSmithKline ADR announced earnings per share of £0.694 on revenue of £12.91B. Analysts polled by Investing.com anticipated EPS of £0.6578 on revenue of £12.79B.
GlaxoSmithKline ADR shares are down 12.26% from the beginning of the year and are trading at £44.66 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
GlaxoSmithKline ADR shares lost 1.24% in pre-market trade the report.
GlaxoSmithKline ADR follows other major Healthcare sector earnings this month
GlaxoSmithKline ADR's report follows an earnings beat by UnitedHealth on January 19, who reported EPS of £4.48 on revenue of £73.74B, compared to forecasts EPS of £4.3 on revenue of £72.98B.
J&J had beat expectations on January 25 with fourth quarter EPS of £2.13 on revenue of £24.8B, compared to forecast for EPS of £2.12 on revenue of £25.28B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar